Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.410
-0.170 (-4.75%)
At close: Jun 11, 2025, 4:00 PM
3.402
-0.008 (-0.25%)
After-hours: Jun 11, 2025, 4:27 PM EDT
Aquestive Therapeutics Employees
Aquestive Therapeutics had 142 employees as of December 31, 2024. The number of employees increased by 7 or 5.19% compared to the previous year.
Employees
142
Change (1Y)
7
Growth (1Y)
5.19%
Revenue / Employee
$381,887
Profits / Employee
-$381,965
Market Cap
338.71M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
AQST News
- 2 days ago - Aquestive Therapeutics: Anaphylm Could Gain Significant Market Share - Seeking Alpha
- 4 weeks ago - Aquestive Therapeutics, Inc. (AQST) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Aquestive Therapeutics: Unprofitable For A Few More Years, But Significant Upside Potential - Seeking Alpha
- 5 weeks ago - Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET - GlobeNewsWire
- 2 months ago - Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium - GlobeNewsWire
- 2 months ago - Aquestive Therapeutics: Oral Anaphylaxis NDA Opportunity Spells Buy - Seeking Alpha
- 3 months ago - Aquestive Therapeutics, Inc. (AQST) Q4 2024 Earnings Call Transcript - Seeking Alpha